| 000 | 01740 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517040104.0 | ||
| 264 | 0 | _c20160504 | |
| 008 | 201605s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0127676 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRakotonjanahary, Josué | |
| 245 | 0 | 0 |
_aMortality in Children with Optic Pathway Glioma Treated with Up-Front BB-SFOP Chemotherapy. _h[electronic resource] |
| 260 |
_bPloS one _c2015 |
||
| 300 |
_ae0127676 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAstrocytoma _xdrug therapy |
| 650 | 0 | 4 |
_aCarboplatin _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aEtoposide _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOptic Nerve Glioma _xdrug therapy |
| 650 | 0 | 4 |
_aProcarbazine _xtherapeutic use |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aVincristine _xtherapeutic use |
| 700 | 1 | _aDe Carli, Emilie | |
| 700 | 1 | _aDelion, Matthieu | |
| 700 | 1 | _aKalifa, Chantal | |
| 700 | 1 | _aGrill, Jacques | |
| 700 | 1 | _aDoz, François | |
| 700 | 1 | _aLeblond, Pierre | |
| 700 | 1 | _aBertozzi, Anne-Isabelle | |
| 700 | 1 | _aRialland, Xavier | |
| 773 | 0 |
_tPloS one _gvol. 10 _gno. 6 _gp. e0127676 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0127676 _zAvailable from publisher's website |
| 999 |
_c25005642 _d25005642 |
||